Takeshi Yokoo1,2, Haley R Clark3, Ivan Pedrosa3,4, Qing Yuan3, Ivan Dimitrov4,5, Yue Zhang3, Ildiko Lingvay6,7, Muhammad S Beg6, I Alexandru Bobulescu6,8. 1. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Takeshi.Yokoo@UTSouthwestern.edu. 2. Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Takeshi.Yokoo@UTSouthwestern.edu. 3. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 4. Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 5. Philips Medical Systems, Cleveland, Ohio, USA. 6. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 7. Department of Clinical Science, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 8. Charles and Jane Pak Center of Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Abstract
PURPOSE: To evaluate renal lipid content in subjects with and without type II diabetes mellitus (DM2) using Dixon-based magnetic resonance imaging (MRI). MATERIALS AND METHODS: This retrospective study was approved by the Institutional Review Board and compliant with the Health Insurance Portability and Accountability Act. Sixty-nine adults with or without DM2 (n = 29, n = 40) underwent 3T MRI of the abdomen using 3D multiecho Dixon gradient-echo acquisition and proton-density fat fraction (FF) reconstruction. FF values were recorded within segmented regions of interest in the kidneys and liver. The FF measurement error was estimated from the within-subject difference between the right and left kidneys using Bland-Altman analysis. Correlation between renal FF, hepatic FF, and body mass index (BMI) was evaluated. The association between renal FF and DM2 was evaluated by Wilcoxon rank sum test as well as by multivariate regression to correct for potential confounding effects of age, sex, BMI, creatinine, and hepatic FF. P < 0.05 was considered statistically significant. RESULTS: Per-subject 95% limits of agreement of the renal FF measurement were [-3.26%, +3.22%]. BMI was significantly correlated with renal FF (r = 0.266, P = 0.027) and with liver FF (r = 0.344, P = 0.006). Correlation between renal and hepatic FF did not reach statistical significance (r = 0.215, P = 0.090). Median renal FF (±interquartile range) was 2.18% (±2.52%) in the DM2 cohort, significantly higher than 0.80% (±2.63%) in the non-DM2 cohort (P < 0.001). After correcting for potential confounders, the relationship between DM2 and renal FF remained statistically significant (P = 0.005). CONCLUSION: Renal lipid content can be measured noninvasively using Dixon-based MRI and may be increased in subjects with DM2 compared to those without DM2. J. Magn. Reson. Imaging 2016;44:1312-1319.
PURPOSE: To evaluate renal lipid content in subjects with and without type II diabetes mellitus (DM2) using Dixon-based magnetic resonance imaging (MRI). MATERIALS AND METHODS: This retrospective study was approved by the Institutional Review Board and compliant with the Health Insurance Portability and Accountability Act. Sixty-nine adults with or without DM2 (n = 29, n = 40) underwent 3T MRI of the abdomen using 3D multiecho Dixon gradient-echo acquisition and proton-density fat fraction (FF) reconstruction. FF values were recorded within segmented regions of interest in the kidneys and liver. The FF measurement error was estimated from the within-subject difference between the right and left kidneys using Bland-Altman analysis. Correlation between renal FF, hepatic FF, and body mass index (BMI) was evaluated. The association between renal FF and DM2 was evaluated by Wilcoxon rank sum test as well as by multivariate regression to correct for potential confounding effects of age, sex, BMI, creatinine, and hepatic FF. P < 0.05 was considered statistically significant. RESULTS: Per-subject 95% limits of agreement of the renal FF measurement were [-3.26%, +3.22%]. BMI was significantly correlated with renal FF (r = 0.266, P = 0.027) and with liver FF (r = 0.344, P = 0.006). Correlation between renal and hepatic FF did not reach statistical significance (r = 0.215, P = 0.090). Median renal FF (±interquartile range) was 2.18% (±2.52%) in the DM2 cohort, significantly higher than 0.80% (±2.63%) in the non-DM2 cohort (P < 0.001). After correcting for potential confounders, the relationship between DM2 and renal FF remained statistically significant (P = 0.005). CONCLUSION: Renal lipid content can be measured noninvasively using Dixon-based MRI and may be increased in subjects with DM2 compared to those without DM2. J. Magn. Reson. Imaging 2016;44:1312-1319.
Authors: Xin Zhang; Zi-Lun Li; John R Woollard; Alfonso Eirin; Behzad Ebrahimi; John A Crane; Xiang-Yang Zhu; Aditya S Pawar; James D Krier; Kyra L Jordan; Hui Tang; Stephen C Textor; Amir Lerman; Lilach O Lerman Journal: Am J Physiol Renal Physiol Date: 2013-05-08
Authors: Aiko P J de Vries; Piero Ruggenenti; Xiong Z Ruan; Manuel Praga; Josep M Cruzado; Ingeborg M Bajema; Vivette D D'Agati; Hildo J Lamb; Drazenka Pongrac Barlovic; Radovan Hojs; Manuela Abbate; Rosa Rodriquez; Carl Erik Mogensen; Esteban Porrini Journal: Lancet Diabetes Endocrinol Date: 2014-05 Impact factor: 32.069
Authors: Jens-Peter Kühn; Friederike Berthold; Julia Mayerle; Henry Völzke; Scott B Reeder; Wolfgang Rathmann; Markus M Lerch; Norbert Hosten; Katrin Hegenscheid; Peter J Meffert Journal: Radiology Date: 2015-02-05 Impact factor: 11.105
Authors: Thomas Loughran; David M Higgins; Michelle McCallum; Anna Coombs; Volker Straub; Kieren G Hollingsworth Journal: Radiology Date: 2015-01-07 Impact factor: 11.105
Authors: Giovanni Musso; Roberto Gambino; James H Tabibian; Mattias Ekstedt; Stergios Kechagias; Masahide Hamaguchi; Rolf Hultcrantz; Hannes Hagström; Seung Kew Yoon; Phunchai Charatcharoenwitthaya; Jacob George; Francisco Barrera; Svanhildur Hafliðadóttir; Einar Stefan Björnsson; Matthew J Armstrong; Laurence J Hopkins; Xin Gao; Sven Francque; An Verrijken; Yusuf Yilmaz; Keith D Lindor; Michael Charlton; Robin Haring; Markus M Lerch; Rainer Rettig; Henry Völzke; Seungho Ryu; Guolin Li; Linda L Wong; Mariana Machado; Helena Cortez-Pinto; Kohichiroh Yasui; Maurizio Cassader Journal: PLoS Med Date: 2014-07-22 Impact factor: 11.069
Authors: Ion Alexandru Bobulescu; Yair Lotan; Jianning Zhang; Tara R Rosenthal; John T Rogers; Beverley Adams-Huet; Khashayar Sakhaee; Orson W Moe Journal: PLoS One Date: 2014-08-29 Impact factor: 3.240
Authors: Yue Zhang; Durga Udayakumar; Ling Cai; Zeping Hu; Payal Kapur; Eun-Young Kho; Andrea Pavía-Jiménez; Michael Fulkerson; Alberto Diaz de Leon; Qing Yuan; Ivan E Dimitrov; Takeshi Yokoo; Jin Ye; Matthew A Mitsche; Hyeonwoo Kim; Jeffrey G McDonald; Yin Xi; Ananth J Madhuranthakam; Durgesh K Dwivedi; Robert E Lenkinski; Jeffrey A Cadeddu; Vitaly Margulis; James Brugarolas; Ralph J DeBerardinis; Ivan Pedrosa Journal: JCI Insight Date: 2017-08-03